Results 1 to 10 of about 11,035 (149)
Recurrent pityriasis rosea: A case report
Human Vaccines and Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
exaly +3 more sources
Indian Journal of Dermatology, 2010 Pityriasis rosea is a frequent papulo-squamous disease and is known for various atypical clinical presentations. We report an adult female patient with a clinical diagnosis of giant pityriasis rosea, which is a rarity in clinical practice.
Zawar Vijay
doaj +4 more sources
A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib [PDF]
Clinical, Cosmetic and Investigational DermatologyHao Wu, Qing-Jie Ji, Yu-Yang Xu, Jian-Wei Zhu Department of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of ChinaCorrespondence: Jian-Wei Zhu, Email zjwmed@
Hao Wu
exaly +3 more sources
Pityriasis Rosea Induced by COVID-19 Vaccination [PDF]
European Journal of Case Reports in Internal Medicine, 2022 It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect ...
Elina Khattab +2 more
doaj +2 more sources
Unilateral pityriasis rosea in a child: A rare clinical presentation [PDF]
The Turkish Journal of Pediatrics, 2017 Pityriasis rosea is a common papulosquamous disorder with occasional variations in lesion morphology, distribution, number and course of disease. The lesions are classically arranged with their long axes parallel to the Langer`s lines of cleavage and ...
Atiye Oğrum
doaj +2 more sources
Immunity, Inflammation and Disease, 2023 Background: After introducing Covid‐19 vaccines, a few side effects were reported, pityriasis rosea being one of them. Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a ...
Iman Khan +5 more
doaj +2 more sources
Acral pityriasis rosea: A rare variant of pityriasis rosea
Dermatology Reports, 2021 Pityriasis rosea (PR) is a common, selflimited inflammatory skin condition, usually affects the trunk and proximal extremities. A variety of atypical manifestations of PR have been recognized ranging from the difference in the morphology, distribution ...
Pimpa Tantanasrigul +2 more
doaj +4 more sources
Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study [PDF]
Acta Dermato-Venereologica, 2019 Pityriasis rosea is a common acute exanthema of unknown aetiology, which causes severe anxiety. In this study, the demographic data of pityriasis rosea patients, who presented to our clinic between 2013 and 2017, were prospectively recorded. The patients
Mavişe Yüksel
doaj +2 more sources
An Atypical Case of Pityriasis Rosea Gigantea after Influenza Vaccination
Case Reports in Dermatology, 2014 Pityriasis rosea is a common erythematosquamous eruption, typically presenting along the cleavage lines of the skin. A wide spectrum of atypical manifestations may challenge even the most experienced physician.
Dimitrios Papakostas +5 more
doaj +4 more sources
A clinical study on pityriasis rosea
Indian Journal of Dermatology, 2005 Pityriasis rosea is an acute inflammatory dermatosis of unknown etiology with a self-limited course. Fifty patients of pityriasis rosea attending out patient department of our hospital were selected for the study and the data was analysed. In the present
Egwin Anand +4 more
doaj +1 more source